bioRxivMicrobiology
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Q. Wang, Z. Li, Y. Guo, I. A. Mellis, S. Iketani, M. Liu, J. Yu, R. Valdez, A. S. Lauring, Z. Sheng, A. Gordon, L. Liu, D. D. Ho
Abstract
SARS-CoV-2 Omicron BA.2.75 has diversified into multiple subvariants with additional spike mutations, and several are expanding in prevalence, particularly CH.1.1 and BN.1. Here, we investigated the viral receptor affinities and neutralization evasion properties of major BA.2.75 subvariants actively circulating in different regions worldwide. We found two distinct evolutionary pathways and three newly identified mutations that shaped the virological features of these subvariants. One phenotypic group exhibited a discernible decrease in viral receptor affinities, but a noteworthy increase in resistance to antibody neutralization, as exemplified by CH.1.1, which is apparently as resistant as XBB.1.5. In contrast, a second group demonstrated a substantial increase in viral receptor affinity but only a moderate increase in antibody evasion, as exemplified by BN.1. We also observed that all prevalent SARS-CoV-2 variants in the circulation presently, except for BN.1, exhibit profound levels of antibody evasion, suggesting this is the dominant determinant of virus transmissibility today.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
Q. Wang, S. Iketani, … D. D. Ho·bioRxiv·Jul 31, 2022
- Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
D. Planas, T. Bruel, … O. Schwartz·bioRxiv·Nov 17, 2022
- Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies
Y. Cao, A. Yisimayi, … X. S. Xie·bioRxiv·Feb 7, 2022
- Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages
S. Iketani, L. Liu, … D. D. Ho·bioRxiv·Feb 7, 2022
- Evasion of neutralizing antibodies by Omicron sublineage BA.2.75
D. J. Sheward, C. Kim, … B. Murrell·bioRxiv·Jul 19, 2022
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5